eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | cardiomyopathy |
| Comorbidity | C0264832|peripartum cardiomyopathy |
| Sentences | 3 |
| PubMedID- 22588321 | Aims: persistence of left ventricular (lv) systolic dysfunction after 6 months of diagnosis is believed to be a marker of an irreversible cardiomyopathy in peripartum cardiomyopathy (ppcm). |
| PubMedID- 22412221 | The prevalence of mutations associated with familial dilated-cardiomyopathy genes in patients with peripartum cardiomyopathy suggests an overlap in the clinical spectrum of these 2 diseases.treatment for peripartum cardiomyopathy includes conventional pharmacologic heart-failure therapies-principally diuretics, angiotensin-converting enzyme inhibitors, vasodilators, digoxin, beta-blockers, anticoagulants, and peripartum cardiomyopathy-targeted therapies. |
| PubMedID- 20027040 | Conclusion: although only a minority of hospitalizations for cardiomyopathy are consistent with peripartum cardiomyopathy, cardiomyopathy and other myocardial disorders are important contributors to severe obstetric complications. |
Page: 1